SXI Life Sciences
6.857,51
PKT
-11,95
PKT
-0,17
%
Werbung
Analysen zu SXI Life Sciences-Werten
Datum | Rating | Analyst | |
---|---|---|---|
14.10.21 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.21 | Roche Outperform | Bernstein Research | |
13.10.21 | Roche Neutral | JP Morgan Chase & Co. | |
13.10.21 | Roche Equal-weight | Morgan Stanley | |
12.10.21 | Novartis Market-Perform | Bernstein Research | |
11.10.21 | Roche Buy | Deutsche Bank AG | |
11.10.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
11.10.21 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.10.21 | Novartis Buy | UBS AG | |
07.10.21 | Novartis Buy | Jefferies & Company Inc. | |
07.10.21 | Roche Buy | Jefferies & Company Inc. | |
05.10.21 | Novartis Underweight | JP Morgan Chase & Co. | |
04.10.21 | Roche Neutral | JP Morgan Chase & Co. | |
30.09.21 | Roche Buy | Deutsche Bank AG | |
29.09.21 | Roche Neutral | UBS AG | |
23.09.21 | Roche Neutral | Credit Suisse Group | |
20.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
20.09.21 | Novartis Sell | Deutsche Bank AG | |
17.09.21 | Novartis Hold | Deutsche Bank AG | |
17.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
15.09.21 | Roche Buy | Deutsche Bank AG | |
15.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
14.09.21 | Novartis Underweight | JP Morgan Chase & Co. | |
13.09.21 | Novartis Hold | Deutsche Bank AG | |
10.09.21 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
10.09.21 | Roche Buy | Deutsche Bank AG | |
10.09.21 | Roche Neutral | JP Morgan Chase & Co. | |
09.09.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
07.09.21 | Roche Neutral | UBS AG | |
07.09.21 | Roche Buy | Jefferies & Company Inc. | |
06.09.21 | Novartis Hold | Kepler Cheuvreux | |
16.08.21 | Roche Buy | Jefferies & Company Inc. | |
09.08.21 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
09.08.21 | Roche Outperform | Bernstein Research | |
04.08.21 | Novartis Buy | UBS AG | |
02.08.21 | Roche Neutral | JP Morgan Chase & Co. | |
28.07.21 | Novartis Underweight | JP Morgan Chase & Co. | |
27.07.21 | Novartis Overweight | Morgan Stanley | |
23.07.21 | Roche Neutral | Credit Suisse Group | |
23.07.21 | Novartis Buy | UBS AG |